UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000041245
Receipt number R000047100
Scientific Title Examination of the influence on the circulatory system by the airway management method using Nasal High Flow load device AIRVO during sedation
Date of disclosure of the study information 2020/07/29
Last modified on 2021/01/28 09:20:57

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Examination of the influence on the circulatory system by the airway management method using Nasal High Flow load device AIRVO during sedation

Acronym

Examination of the influence on the circulatory system by the airway management method using Nasal High Flow load device AIRVO during sedation

Scientific Title

Examination of the influence on the circulatory system by the airway management method using Nasal High Flow load device AIRVO during sedation

Scientific Title:Acronym

Examination of the influence on the circulatory system by the airway management method using Nasal High Flow load device AIRVO during sedation

Region

Japan


Condition

Condition

DENTISTRY

Classification by specialty

Anesthesiology Dental medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to investigate whether the application of NHF increases the intrathoracic pressure and decreases the afterload, and secondarily increases the cardiac output.

Basic objectives2

Others

Basic objectives -Others

The purpose of this study is to investigate whether the application of NHF increases the intrathoracic pressure and decreases the afterload, and secondarily increases the cardiac output.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Estimated afterload and cardiac output during waking and sedation

Key secondary outcomes

Tidal volume and respiratory rate during waking and sedation


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Twenty adult healthy volunteers (volunteers) who agreed with the explanation of the content of the research plan are targeted.

Key exclusion criteria

1) Patients with serious respiratory illness (asthma)
2) Patients with serious cardiovascular disease (congenital heart disease)
3) Uncontrolled diabetic patients
4) Patients with severe renal impairment
5) Patients with severe liver damage
6) Patients with hypersensitivity (allergy) to the drug to be used
7) Patients judged to be unsuitable by the research supervisor or the research co-workers

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Takao
Middle name
Last name Ayuse

Organization

Nagasaki University

Division name

Dental Anesthesiology

Zip code

8528588

Address

Sakamoto Nagasaki Japan

TEL

81958197713

Email

ayuse@nagasaki-u.ac.jp


Public contact

Name of contact person

1st name Takao
Middle name
Last name Ayuse

Organization

Nagasaki University

Division name

Dental Anesthesiology

Zip code

8528588

Address

Sakamoto Nagasaki Japan

TEL

81958197713

Homepage URL


Email

ayuse@nagasaki-u.ac.jp


Sponsor or person

Institute

Nagasaki University

Institute

Department

Personal name



Funding Source

Organization

Nagasaki University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nagasaki University

Address

Sakamoto Nagasaki Japan

Tel

81958197713

Email

ayuse@nagasaki-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 07 Month 29 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2020 Year 05 Month 11 Day

Date of IRB

2020 Year 07 Month 29 Day

Anticipated trial start date

2020 Year 08 Month 01 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

NONE


Management information

Registered date

2020 Year 07 Month 29 Day

Last modified on

2021 Year 01 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047100


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name